Their findings, published today in the journal Proceedings of the National Academy of Sciences, provide a foundation for ...
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...
Clinical relevance: Receptor engineering has significantly advanced NK cell-based cancer immunotherapies. As technical hurdles are overcome, these innovative treatments are poised to revolutionize ...
So instead, Rezvani decided to add the CAR gene to natural killer (NK) cells. “These cells are part of the innate immune system, and they’re very good at recognizing and killing cancer cells ...